Two posters presented at the CHEST Annual Meeting 2023 showed how real-world exacerbation rates in asthma and chronic obstructive pulmonary disease (COPD) dropped after patients started using a single ...

The maintenance inhalers available for obstructive lung disease are long-acting beta-agonists (LABAs), long-acting muscarinic antagonists (LAMAs), and inhaled corticosteroids (ICSs). We use all three ...

Research indicates at least 55% of patients with COPD receive ICS as first-line therapy, even though such therapy is recommended only for those with an exacerbation history, asthma, or elevated ...

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — A subgroup analysis of the KRONOS study showed the reduction in COPD exacerbations observed with ...

Woman suffering an anxiety attack alone in the night How does a delay in initiating triple therapy affect patients with COPD with a history of several moderate COPD exacerbations during a 1-year ...

Then Martin glanced up at the TV in his room and saw something that changed his life. A local news channel was airing a segment on “Harmonicas for Health,” a program from the COPD Foundation to teach ...

Triple therapy for COPD combines three inhaled medications to help you breathe easier. This can include medications to reduce swelling, widen the airway, and relax the muscles in your airway. To treat ...

If you have chronic obstructive pulmonary disease (COPD), your airways may be inflamed. It may be hard to take deep breaths and get enough oxygen. Depending on the severity of your COPD, oxygen ...

The FDA approved inhaled ensifentrine (Ohtuvayre) as maintenance treatment for chronic obstructive pulmonary disease (COPD) in adults, drugmaker Verona Pharma announced on Wednesday. A first-in-class ...